Cargando…

Prediction of Pseudoprogression versus Progression using Machine Learning Algorithm in Glioblastoma

We aimed to investigate the feasibility of machine learning (ML) algorithm to distinguish pseudoprogression (PsPD) from progression (PD) in patients with glioblastoma (GBM). We recruited the patients diagnosed as primary GBM who received gross total resection (GTR) and concurrent chemoradiotherapy i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Bum-Sup, Jeon, Seung Hyuck, Kim, Il Han, Kim, In Ah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104063/ https://www.ncbi.nlm.nih.gov/pubmed/30131513 http://dx.doi.org/10.1038/s41598-018-31007-2

Ejemplares similares

Machine Learning Model to Predict Pseudoprogression Versus Progression in Glioblastoma Using MRI: A Multi-Institutional Study (KROG 18-07)
por: Jang, Bum-Sup, et al.
Publicado: (2020)

True Progression versus Pseudoprogression in the Treatment of Glioblastomas: A Comparison Study of Normalized Cerebral Blood Volume and Apparent Diffusion Coefficient by Histogram Analysis
por: Song, Yong Sub, et al.
Publicado: (2013)

Pseudoprogression as an adverse event of glioblastoma therapy
por: Balaña, Carmen, et al.
Publicado: (2017)

The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma
por: Xi, Jing, et al.
Publicado: (2021)

Glioblastoma pseudoprogression and true progression reveal spatially variable transcriptional differences
por: Wang, Wesley, et al.
Publicado: (2023)

Differentiation of pseudoprogression and real progression in glioblastoma using ADC parametric response maps
por: Reimer, Caroline, et al.
Publicado: (2017)

High levels of cellular proliferation predict pseudoprogression in glioblastoma patients
por: POULEAU, HENRI-BENJAMIN, et al.
Publicado: (2011)

Radiomic Analysis to Predict Histopathologically Confirmed Pseudoprogression in Glioblastoma Patients
por: McKenney, Anna Sophia, et al.
Publicado: (2022)

Exploration of biomedical knowledge for recurrent glioblastoma using natural language processing deep learning models
por: Jang, Bum-Sup, et al.
Publicado: (2022)

NEIM-02 DEVELOPMENT OF A DEEP LEARNING MODEL FOR DISCRIMINATING TRUE PROGRESSION FROM PSEUDOPROGRESSION IN GLIOBLASTOMA PATIENTS
por: Moassefi, Mana, et al.
Publicado: (2022)

A preliminary quantitative proteomic analysis of glioblastoma pseudoprogression
por: Zhang, Peng, et al.
Publicado: (2015)

Glioblastoma with brainstem leptomeningeal pseudoprogression following radiation therapy
por: Kinger, Nikhar, et al.
Publicado: (2019)

Radiomics: The New Promise for Differentiating Progression, Recurrence, Pseudoprogression, and Radionecrosis in Glioma and Glioblastoma Multiforme
por: Alizadeh, Mohammadreza, et al.
Publicado: (2023)

Validation of multiparametric MRI based prediction model in identification of pseudoprogression in glioblastomas
por: de Godoy, Laiz Laura, et al.
Publicado: (2023)

Apatinib combined with temozolomide treatment for pseudoprogression in glioblastoma: A case report
por: Zhao, Mingming, et al.
Publicado: (2022)

A Radiosensitivity Gene Signature and PD-L1 Status Predict Clinical Outcome of Patients with Glioblastoma Multiforme in The Cancer Genome Atlas Dataset
por: Jang, Bum-Sup, et al.
Publicado: (2020)

Analysis of heterogeneity in T(2)-weighted MR images can differentiate pseudoprogression from progression in glioblastoma
por: Booth, Thomas C., et al.
Publicado: (2017)

Magnetic resonance spectroscopy outperforms perfusion in distinguishing between pseudoprogression and disease progression in patients with glioblastoma
por: El-Abtah, Mohamed E, et al.
Publicado: (2022)

Pseudoprogression in Glioblastoma: Role of Metabolic and Functional MRI-Systematic Review
por: Sidibe, Ingrid, et al.
Publicado: (2022)

Relationship between Macrophage and Radiosensitivity in Human Primary and Recurrent Glioblastoma: In Silico Analysis with Publicly Available Datasets
por: Jang, Bum-Sup, et al.
Publicado: (2022)

A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma
por: Kebir, Sied, et al.
Publicado: (2020)

Stratification of pseudoprogression and true progression of glioblastoma multiform based on longitudinal diffusion tensor imaging without segmentation
por: Qian, Xiaohua, et al.
Publicado: (2016)

Three‐dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastoma
por: Verma, Gaurav, et al.
Publicado: (2018)

Early Pseudoprogression following Chemoradiotherapy in Glioblastoma Patients: The Value of RANO Evaluation
por: Linhares, Paulo, et al.
Publicado: (2013)

BIMG-12. [18F]FLUCICLOVINE PET TO DISTINGUISH PSEUDOPROGRESSION FROM TUMOR PROGRESSION IN POST-TREATMENT GLIOBLASTOMA
por: Nabavizadeh, Ali, et al.
Publicado: (2021)

Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma
por: Li, Yan, et al.
Publicado: (2021)

Multiple oligodendroglioma with pseudoprogression
por: Matsuyama, Junko
Publicado: (2012)

Pseudoprogression of brain tumors
por: Thust, Stefanie C., et al.
Publicado: (2018)

Pseudoprogression and Immunotherapy Phenomena
por: Waxman, Elizabeth S., et al.
Publicado: (2020)

Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival
por: Hu, Leland S., et al.
Publicado: (2012)

Radiation Response Prediction Model Based on Integrated Clinical and Genomic Data Analysis
por: Jang, Bum-Sup, et al.
Publicado: (2022)

The Potential Use of Radiomics with Pre-Radiation Therapy MR Imaging in Predicting Risk of Pseudoprogression in Glioblastoma Patients
por: Baine, Michael, et al.
Publicado: (2021)

Discriminating pseudoprogression and true progression in diffuse infiltrating glioma using multi-parametric MRI data through deep learning
por: Lee, Joonsang, et al.
Publicado: (2020)

Restriction Spectrum Imaging Differentiates True Tumor Progression From Immune-Mediated Pseudoprogression: Case Report of a Patient With Glioblastoma
por: Daghighi, Shadi, et al.
Publicado: (2020)

Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological, and Molecular Features
por: Li, Mingxiao, et al.
Publicado: (2021)

Differentiating tumour progression from pseudoprogression in glioblastoma patients: a monoexponential, biexponential, and stretched-exponential model-based DWI study
por: Liao, Dan, et al.
Publicado: (2023)

Predicting progression to dementia with “comprehensive visual rating scale” and machine learning algorithms
por: Park, Chaeyoon, et al.
Publicado: (2022)

Assessing the added value of apparent diffusion coefficient, cerebral blood volume, and radiomic magnetic resonance features for differentiation of pseudoprogression versus true tumor progression in patients with glioblastoma
por: Leone, Riccardo, et al.
Publicado: (2023)

Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T(1)-weighted Contrast-enhanced Imaging
por: Sun, Ying-Zhi, et al.
Publicado: (2021)

Pseudoprogression in low-grade glioma
por: Slater, Jason M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a1msd5ha2gtsh6e47egf8l60io